Close Menu

NEW YORK – A multi-omic analysis of high-grade serous ovarian cancer has uncovered molecular differences between clinical subgroups of the disease.

Ovarian cancer is common and aggressive, affecting about 22,500 people in the US each year, according to the National Cancer Institute. It also exhibits high levels of tumor heterogeneity and clinical outcomes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.